Indeed, the CD44+/CD24−/low status commonly used to identify tumor-initiating breast cancer cells is present in a substantial fraction of cells derived from pleural effusions or from ER-negative breast cancer cell lines and xenografts, whereas it is detectable in a lower fraction of cells from ER-positive tumors, even growing as non-adherent mammospheres. This evidence concerns the gene ESR1 and breast carcinoma.